Clinical Trials Browser

Active not recruiting × Neuroendocrine Tumors × 90Y-octreotide, DOTA-Tyr(3)- × Clear all

NCT03044977 2023-08-16

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Phase EARLY_PHASE1 Active not recruiting

Neuroendocrine Tumors